Condition (MeSH)
Pemphigoid, Bullous
ClinicalTrials.gov lists 62 trials for Pemphigoid, Bullous or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 more section with rows
62 of the 62 trials are tagged with Pemphigoid, Bullous itself; the rest are tagged with a narrower condition beneath it.
When did Pemphigoid, Bullous trials start? (22)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 4 |
| 2023 | 2 |
| 2022 | 8 |
| 2021 | 3 |
| 2020 | 8 |
| 2018 | 3 |
| 2017 | 5 |
| 2016 | 3 |
Showing 10 of 22 earlier years.
No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pemphigoid, Bullous trials in? (9)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 4 |
| Phase 1/2 | 3 |
| Phase 2 | 13 |
| Phase 2/3 | 2 |
| Phase 3 | 9 |
| Phase 4 | 4 |
| Not applicable | 4 |
| Observational | 22 |
| Expanded access | 1 |
How many Pemphigoid, Bullous trials are recruiting? (9)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 32 |
Showing 5 of 9 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pemphigoid, Bullous trials? (9)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AKARI Therapeutics | 2 |
| Chugai Pharmaceutical | 2 |
| Nihon Pharmaceutical Co., Ltd | 2 |
| Regeneron Pharmaceuticals | 2 |
| argenx | 2 |
Showing 5 of 9 sponsors.
Which drugs are being tested for Pemphigoid, Bullous? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| RITUXIMAB | 3 |
| Prednisone | 3 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Dupilumab/Dupixent | 3 |
| Globulin, Immune | 2 |
| RAY121 | 2 |
| Efgartigimod PH20 (ARGX-113) SC | 2 |
| treatment with topical superpotent corticosteroid therapy | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pemphigoid, Bullous trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pemphigoid | 14 | 3 |
| Urinary tract infection | 7 | 3 |
| Pneumonia | 6 | 4 |
| Cardiac failure | 5 | 3 |
| Sepsis | 5 | 4 |
Showing 5 of 10 adverse events.
Which publications cover Pemphigoid, Bullous? (66)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT. | Advances in therapy | 2024 | Yes |
| Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein. | Journal of dermatological science | 2024 | Yes |
| Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease. | Journal of advanced research | 2023 | Yes |
| Immune cells in pemphigus vulgaris and bullous Pemphigoid: From pathogenic roles to targeting therapies. | International immunopharmacology | 2023 | Yes |
| Global incidence and prevalence of bullous pemphigoid: A systematic review and meta-analysis. | Journal of cosmetic dermatology | 2022 | Yes |
Showing 5 of 66 publications.
Prevalence (18)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Bullous pemphigoid | Annual incidence | 1-9 / 100 000 | United Kingdom | GB | Unspecified |
| Bullous pemphigoid | Annual incidence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Bullous pemphigoid | Annual incidence | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Bullous pemphigoid | Annual incidence | 1-9 / 100 000 | Switzerland | Not stated | Exact |
| Bullous pemphigoid | Annual incidence | 1-9 / 100 000 | France | Not stated | Unspecified |
Showing 5 of 18 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Bullous pemphigoid | 703 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Bullous pemphigoid | 703 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.